1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Spectrum Pharmaceuticals Inc (SPPI)
  7. Quote


Spectrum Pharmaceuticals Stock Price

-0.12 (-7.59%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 3,553,023
Bid Price 1.40
Ask Price 1.49
News -
Day High 1.58


52 Week Range


Day Low 1.35
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Spectrum Pharmaceuticals Inc SPPI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -7.59% 1.46 00:00:14
Open Price Low Price High Price Close Price Prev Close
1.58 1.35 1.58 1.37 1.58
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,181 3,553,023 $ 1.45 $ 5,142,451 - 1.35 - 5.24
Last Trade Time Type Quantity Stock Price Currency
19:45:47 formt 300 $ 1.46 USD


Draw Mode:

Spectrum Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 239.38M 163.96M 133.71M $ - $ - -1.28 -1.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 2.30%

more financials information »

Spectrum Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SPPI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.741.811.351.627,931,121-0.28-16.09%
1 Month2.402.421.351.774,927,699-0.94-39.17%
3 Months2.222.531.351.973,191,468-0.76-34.23%
6 Months3.854.541.352.602,984,913-2.39-62.08%
1 Year4.765.241.353.042,765,263-3.30-69.33%
3 Years14.5714.651.354.231,951,876-13.11-89.98%
5 Years4.0025.291.357.521,652,510-2.54-63.5%

Spectrum Pharmaceuticals Description

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. As an oncology products manufacturer, it develops drugs to combat various kinds of tumors. The SPI-2012 is being developed for chemotherapy-induced neutropenia in patients with breast cancer, and EOQUIN addresses immediate intravesical instillation and post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer.

Your Recent History
Spectrum P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.